@article {171,
	title = {Management of sympathetic ophthalmia with the fluocinolone acetonide implant.},
	journal = {Ophthalmology},
	volume = {116},
	year = {2009},
	month = {2009 Mar},
	pages = {552-557.e1},
	abstract = {<p>We examined whether implantation of the fluocinolone acetonide (Retisert) implant achieved control of inflammation and a reduced need for oral corticosteroids or immunosuppressives in patients with sympathetic ophthalmia (SO).</p>
},
	keywords = {Adult, Aged, Drug Implants, Female, Fluocinolone Acetonide, Follow-Up Studies, Glucocorticoids, Humans, Immunosuppressive Agents, Intraocular Pressure, Male, Middle Aged, Ophthalmia, Sympathetic, Retrospective Studies, Treatment Outcome, Visual Acuity},
	author = {Mahajan, Vinit B and Gehrs, Karen M and Goldstein, Debra A and Fischer, David H and Lopez, Juan S and Folk, James C}
}
